Aquestive Therapeutics

-$0.34 (-8.83%) Today
+$0.04 (+1.14%) As of 8:58 AM UTC after-hours

Why Robinhood?

You can buy or sell AQST and other stocks, options, and ETFs commission-free!

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.

CEO
Keith J. Kendall
Employees
187
Headquarters
Warren, New Jersey
Founded
2004

AQST Key Statistics

Market Cap
131.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
628.82K
High Today
$3.89
Low Today
$3.46
Open Price
$3.88
Volume
797.19K
52 Week High
$9.47
52 Week Low
$3.46

AQST Earnings

-$0.69
-$0.48
-$0.28
-$0.07
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.43 per share
Actual
-$0.41 per share
Replay Earnings Call

You May Also Like

BAC-B
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure